background image

Paid Clinical Trials Montreal

Discover 1,152 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: 40 recruiting locations
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT06788990

Phase2, Phase3, Recruiting
Active & Responsive

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

for
Parkinson's Disease (PD)
Location: 30 recruiting locations
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06107426

Recruiting
Active & Responsive

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

for
Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa,
Location: 26 recruiting locations
Sponsor: Target PharmaSolutions, Inc.

Sex: All

Age: 0+

Code: NCT03661866

Recruiting
New

Daridorexant for Alzheimer Disease Prevention

for
Alzheimer Disease (AD)
Location: 1 recruiting location
Sponsor: Douglas Mental Health University Institute

Sex: All

Age: 50 - 70+

Code: NCT07213349

Phase2, Recruiting
New

Methionine Intake Microbiota

for
Healthy
Location: 1 recruiting location
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 20 - 50

Code: NCT07283328

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

for
CNS Embryonal Tumor, CNS, Medulloblastoma,
Location: 2 recruiting locations
Sponsor: C17 Council

Sex: All

Age: 0 - 6

Code: NCT06942039

Early_phase1, Recruiting
New

Efficacy of a Multidomain Intervention on Lifestyle Risk Factors for Dementia Prevention

for
Risk Behavior, Cognitive Decline
Location: 1 recruiting location
Sponsor: LuciLab

Sex: All

Age: 50 - 70+

Code: NCT06748625

Phase3, Recruiting
New

ACT_for Alcohol Use Disorder and Depression

for
Depression - Major Depressive Disorder, Alcohol Use Disorder
Location: 1 recruiting location
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18 - 70

Code: NCT06620276

Recruiting
New

A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostate Cancer
Location: 1 recruiting location
Sponsor: Bayer

Sex: Male

Age: 18+

Code: NCT06052306

Phase1, Recruiting
New

A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation

for
Atrial Fibrillation
Location: 5 recruiting locations
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07217067

Phase2, Recruiting